Skip to main content

Diametric Capital, LP

Source: SEC Form 13F · as of Mar 2026

Diametric Capital, LP holds 47 biotech & pharma companies tracked by BioSniper, totaling $62.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

47

Total value held

$62.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for PRECIGEN, INC. (PGEN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PGENPRECIGEN, INC.6,801,788$26.3M
LQDALiquidia Corp167,760$6.3M
FLGTFulgent Genetics Inc.361,046$5.7M
HROWHARROW, INC.110,698$3.9M
ABEOABEONA THERAPEUTICS INC.611,520$2.7M
VKTXViking Therapeutics, Inc.63,896$2.1M
SLNOSOLENO THERAPEUTICS INC57,832$1.9M
RVMDREVOLUTION MEDICINES, INC.15,000$1.5M
AQSTAquestive Therapeutics, Inc.335,443$1.4M
ABVXAbivax SA10,000$1.1M
OCULOCULAR THERAPEUTIX, INC125,000$1.1M
ZVRAZEVRA THERAPEUTICS, INC.108,024$1.0M
ANIPANI PHARMACEUTICALS INC11,840$910K
NKTRNEKTAR THERAPEUTICS7,411$533K
BIVIBIOVIE INC.370,000$518K
ADMAADMA BIOLOGICS, INC.52,005$469K
ACADACADIA PHARMACEUTICALS INC20,842$464K
QUREuniQure N.V.18,395$301K
NUVBNuvation Bio Inc.67,627$290K
ESPREsperion Therapeutics, Inc.102,955$282K
CTMXCytomX Therapeutics, Inc.57,475$270K
PLXProtalix BioTherapeutics, Inc.124,195$270K
AUTLAutolus Therapeutics plc178,731$247K
RNACCartesian Therapeutics, Inc.38,069$234K
OCGNOcugen, Inc.115,152$208K
GRCEGrace Therapeutics, Inc.39,796$184K
RLMDRELMADA THERAPEUTICS, INC.24,006$167K
BBOTBridgeBio Oncology Therapeutics, Inc.16,280$146K
IMMXImmix Biopharma, Inc.14,539$132K
XFORX4 Pharmaceuticals, Inc28,973$120K
IVVDInvivyd, Inc.87,807$114K
LXRXLEXICON PHARMACEUTICALS, INC.67,841$106K
OVIDOvid Therapeutics Inc.43,262$96K
ZURAZura Bio Ltd15,681$93K
LCTXLineage Cell Therapeutics, Inc.59,029$93K
CCCCC4 Therapeutics, Inc.34,594$91K
SGMOQSANGAMO THERAPEUTICS, INC353,477$87K
PROKPROKIDNEY CORP.47,827$86K
CLYMClimb Bio, Inc.11,218$77K
CAMPCamp4 Therapeutics Corp14,446$64K
SABSSAB BIOTHERAPEUTICS, INC.16,292$62K
SGMTSagimet Biosciences Inc.10,043$52K
GALTGALECTIN THERAPEUTICS INC17,089$48K
INOINOVIO PHARMACEUTICALS, INC.24,491$43K
PRLDPrelude Therapeutics Inc11,980$41K
BDTXBlack Diamond Therapeutics, Inc.15,386$33K
ABPOAbpro Holdings, Inc.358,427$1K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.